 | Up a level |
Hehlmann, Rüdiger; Müller, Martin C; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schreiber, Annette; Proetel, Ulrike; Pletsch, Nadine; Pfirrmann, Markus; Haferlach, Claudia; Schnittger, Susanne; Einsele, Hermann; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; ... (2014). Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. Journal of clinical oncology, 32(5), pp. 415-423. American Society of Clinical Oncology 10.1200/JCO.2013.49.9020
Nebe, Thoms; Bentzien, Frank; Bruegel, Mathias; Fiedler, Georg Martin; Gutensohn, Kai; Heimpel, Hermann; Krebs, Nicole; Ossendorf, Manfred; Schuff-Werner, Peter; Stamminger, Gudrun; Baum, Hansjörg (2011). Multicentric Determination of Reference Ranges for Automated Blood Counts. LaboratoriumsMedizin / Journal of laboratory medicine, 35(1), pp. 3-28. Berlin: De Gruyter 10.1515/JLM.2011.004
Heimpel, Hermann; Dührsen, Ulrich; Hofbauer, P; Rigamonti-Wermlinger, V; Kreuser, Ernst-Dietrich; Schwarz, Klaus; Solenthaler, Max; Pauls, S (2009). Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia. Annals of hematology, 88(10), pp. 937-41. Berlin: Springer 10.1007/s00277-009-0735-5
Hehlmann, Rüdiger; Berger, Ute; Pfirrmann, Markus; Heimpel, Hermann; Hochhaus, Andreas; Hasford, Joerg; Kolb, Hans-Jochem; Lahaye, Tanja; Maywald, Ole; Reiter, Andreas; Hossfeld, Dieter K; Huber, Christoph; Löffler, Helmut; Pralle, Hans; Queisser, Wolfgang; Tobler, Andreas; Nerl, Christoph; Solenthaler, Max; Goebeler, Mariele E; Griesshammer, Martin; ... (2007). Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Blood, 109(11), pp. 4686-92. Washington, D.C.: American Society of Hematology 10.1182/blood-2006-11-055186
